Latest data from May 6, 2022
Number of Health Center respondents = 23 (77% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 1,631 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 47.03% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 177 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 38.18% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 49.79% | 57.63% |
| White, Hispanic/Latino Patients | 18.88% | 14.69% |
| Black/African American, Non-Hispanic/Latino Patients | 2.58% | 2.82% |
| Black/African American, Hispanic/Latino Patients | 0.12% | 0.56% |
| Asian Patients3 | 3.13% | 3.39% |
| American Indian/Alaska Native Patients3 | 9.99% | 5.08% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.61% | 1.69% |
| Patients with More Than One Race3 | 3.07% | 1.13% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 5.82% | 6.21% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.92% | 1.13% |
| Unreported/Refused to Report Race and Ethnicity | 5.09% | 5.65% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 641 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 58.08% |
| COVID-19 Immunization Series Completed | 392 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 48.70% |
| COVID-19 Immunization Series Additional | 1,701 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 40.96% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 38.85% | 45.15% | 52.20% |
| White, Hispanic/Latino Patients | 23.56% | 22.45% | 23.87% |
| Black/African American, Non-Hispanic/Latino Patients | 6.40% | 3.57% | 1.35% |
| Black/African American, Hispanic/Latino Patients | 0.47% | 0.51% | 0.12% |
| Asian Patients3 | 4.99% | 3.06% | 1.76% |
| American Indian/Alaska Native Patients3 | 2.34% | 3.32% | 1.47% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.94% | 1.02% | 0.29% |
| Patients with More Than One Race3 | 0.78% | 1.28% | 0.65% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 14.35% | 7.65% | 6.70% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.34% | 2.30% | 1.65% |
| Unreported/Refused to Report Race and Ethnicity | 4.99% | 9.69% | 9.94% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 21.74% |
| 1 to 24 Hours | 30.43% |
| More Than 24 Hours | 39.13% |
| N/A | 8.70% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 4.35% |
| Staffing to administer the vaccine | 21.74% |
| Vaccine confidence | 34.78% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 0.00% |
| Other | 4.35% |
| None | 43.48% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 0.00% |
| Average Percent of Health Center Visits Conducted Virtually | 18.26% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 30.43% |
| Number of Mobile Van Sites | 16 |
| Number of Pop-up Clinics | 1 |
| Number of School-Based Vaccination Sites | 0 |
| Number of Family Vaccination Clinics | 26 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 26.09% |
| Refer patients to another organization that provides monoclonal antibody therapies | 43.48% |
| None | 34.78% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 13.04% |
| Patient awareness/education | 4.35% |
| Staffing capacity | 17.39% |
| Therapy administration/onsite logistics | 13.04% |
| Other | 8.70% |
| None | 65.22% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 11 |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 2,924 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 63.64% |
| Provided to General Public Who Came to the Health Center | 63.64% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 18.18% |
| Provided at Other Community Events | 9.09% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 9.09% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 9.09% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 9.09% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 9.09% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 0.00% |
| Other | 18.18% |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 8 |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 2,893 |
N95 Mask Distribution Methods5
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 87.50% |
| Provided to General Public Who Came to the Health Center | 62.50% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 25.00% |
| Provided at Other Community Events | 12.50% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 25.00% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 12.50% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 12.50% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 0.00% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 0.00% |
| Other | 0.00% |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 7 |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 59.38% |
Oral Antiviral Medication Distribution by Race and Ethnicity
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 37.50% |
| White, Hispanic/Latino Patients | 53.12% |
| Black/African American, Non-Hispanic/Latino Patients | 0.00% |
| Black/African American, Hispanic/Latino Patients | 0.00% |
| Asian Patients3 | 3.12% |
| American Indian/Alaska Native Patients3 | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% |
| Patients with More Than One Race3 | 3.12% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
| Unreported/Refused to Report Race and Ethnicity | 3.12% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 0.00% |
| Patients Experiencing Homelessness | 0.00% |
| Patients Who Are Residents of Public Housing | 9.38% |
| Patients with Limited English Proficiency | 28.12% |
| Children Under 18 Years of Age | 0.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.
Date Last Reviewed: